Effect of Pravastatin on Outcomes after Cardiac Transplantation

Abstract

After cardiac transplantation, pravastatin had beneficial effects on cholesterol levels, the incidence of rejection causing hemodynamic compromise, one-year survival, and the incidence of coronary vasculopathy.